BackCadrenal Therapeutics Overview
Cadrenal Therapeutics Inc

Cadrenal Therapeutics Discounted Cash Flow

DCF Analysis for CVKD.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$2.01

Current Fair Value

$2.01
42.6% Downside

Overvalued by 42.6% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading